你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能!
申请号 | 产品号 | 商品名 | 活性成分 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 申请机构 | 批准时间 | 参比制剂 | 标准制剂 | 市场状态 | TE |
---|---|---|---|---|---|---|---|---|---|---|---|---|
(ANDA) 218684 | 001 | IBUPROFEN AND FAMOTIDINE | FAMOTIDINE; IBUPROFEN | 法莫替丁;布洛芬 | TABLET;ORAL | 26.6MG;800MG | ZYDUS PHARMS | 2025-02-20 | No | No | RX | AB |
(ANDA) 217241 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | STRIDES PHARMA | 2025-01-17 | No | No | OTC | |
(ANDA) 214789 | 001 | IBUPROFEN | IBUPROFEN | 布洛芬 | SUSPENSION;ORAL | 100MG/5ML | PAI HOLDINGS PHARM | 2024-11-08 | No | No | OTC | |
(ANDA) 218247 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | DR REDDYS | 2024-08-23 | No | No | OTC | |
(ANDA) 202413 | 004 | IBUPROFEN | IBUPROFEN | 布洛芬 | TABLET;ORAL | 300MG | SHANDONG XINHUA | 2024-07-05 | No | No | RX | |
(ANDA) 218311 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | GLENMARK PHARMS LTD | 2024-04-26 | No | No | OTC | |
(ANDA) 211404 | 001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN | 枸橼酸苯海拉明;布洛芬 | TABLET;ORAL | 38MG;200MG | PLD ACQUISITIONS LLC | 2024-04-11 | No | No | OTC | |
(ANDA) 213506 | 001 | IBUPROFEN | IBUPROFEN | 布洛芬 | SUSPENSION/DROPS;ORAL | 40MG/ML | AUROBINDO PHARMA LTD | 2024-04-08 | No | No | DISCN | |
(ANDA) 218359 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | AUROBINDO PHARMA LTD | 2024-03-26 | No | No | OTC | |
(ANDA) 203658 | 001 | IBUPROFEN AND FAMOTIDINE | FAMOTIDINE; IBUPROFEN | 法莫替丁;布洛芬 | TABLET;ORAL | 26.6MG;800MG | ENDO OPERATIONS | 2024-03-22 | No | No | RX | AB |
(ANDA) 215925 | 001 | IBUPROFEN AND FAMOTIDINE | FAMOTIDINE; IBUPROFEN | 法莫替丁;布洛芬 | TABLET;ORAL | 26.6MG;800MG | TORRENT | 2024-03-18 | No | No | DISCN | |
(ANDA) 217236 | 001 | IBUPROFEN | IBUPROFEN | 布洛芬 | CAPSULE;ORAL | EQ 200MG FREE ACID AND POTASSIUM SALT | PATHEON SOFTGELS | 2024-02-13 | No | No | OTC | |
(NDA) 215320 | 001 | COMBOGESIC IVP | ACETAMINOPHEN; IBUPROFEN SODIUM | 布洛芬钠;对乙酰氨基酚 | SOLUTION;INTRAVENOUS | 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) | HIKMA | 2023-10-17 | Yes | Yes | RX | |
(ANDA) 215777 | 001 | IBUPROFEN | IBUPROFEN | 布洛芬 | CAPSULE;ORAL | EQ 200MG FREE ACID AND POTASSIUM SALT | AUROBINDO PHARMA LTD | 2023-09-14 | No | No | OTC | |
(ANDA) 217261 | 001 | IBUPROFEN | IBUPROFEN | 布洛芬 | SUSPENSION/DROPS;ORAL | 40MG/ML | TARO | 2023-08-08 | No | No | OTC | |
(ANDA) 216999 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | BIONPHARMA | 2023-08-01 | No | No | OTC | |
(ANDA) 216592 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | GRANULES | 2023-07-13 | No | No | OTC | |
(ANDA) 216994 | 001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 对乙酰氨基酚;布洛芬 | TABLET;ORAL | 250MG;125MG | MARKSANS PHARMA | 2023-07-10 | No | No | OTC | |
(ANDA) 216814 | 001 | IBUPROFEN AND FAMOTIDINE | FAMOTIDINE; IBUPROFEN | 法莫替丁;布洛芬 | TABLET;ORAL | 26.6MG;800MG | ASCENT PHARMS INC | 2023-03-15 | No | No | RX | AB |
(ANDA) 213565 | 001 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE | 布洛芬;盐酸伪麻黄碱 | TABLET;ORAL | 200MG;30MG | AUROBINDO PHARMA LTD | 2023-03-10 | No | No | DISCN |